MARY J FIDLER
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology CHICAGO, IL NPI 1598960494
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology IL Novocure Inc. All categories
General Payments — all program years on this page
$232,298.76
- Category: General Payments
- Program years: PY2018–2024
- Record count: 203
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $65,528.60 across 61 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $56,309.07 | 18 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,750.00 | 1 |
| Travel and Lodging | $2,596.31 | 9 |
| Food and Beverage | $1,873.22 | 33 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novocure Inc. | $21,304.77 | 16 |
| Acerta Pharma LLC | $11,642.47 | 14 |
| Gilead Sciences, Inc. | $8,230.72 | 3 |
| Lilly USA, LLC | $7,600.00 | 3 |
| EMD Serono, Inc. | $7,600.00 | 2 |
| Daiichi Sankyo Inc. | $6,196.16 | 14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,220.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $325.00 | 1 |
| AstraZeneca UK Limited | $157.79 | 3 |
| Coherus Biosciences Inc. | $142.27 | 1 |
| PFIZER INC. | $40.25 | 1 |
| Amgen Inc. | $37.32 | 1 |
| Genentech USA, Inc. | $31.85 | 1 |
By program year
Records — PY2024 (61)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.